Original English content reproduced with permission. Source claims have not been independently validated by Peps MN. Peptide DB ↗
Cardiogen (AEDR)
AEDR | Cardiovascular Bioregulator Peptide
10-20 mg daily
Once daily for 10-20 consecutive days
10-20 days per cycle
Capsules: room temperature; Injectable lyophilized: 2-8°C; Reconstituted: 2-8°C refrigerated
Original Peptide DB content reproduced with permission. Source claims have not been independently validated by Peps MN. Source ↗
Cardiogen is a Khavinson bioregulator peptide consisting of four amino acids, derived from heart tissue research. Unlike larger peptides that work on cell surfaces, Cardiogen penetrates directly to the cell nucleus where it binds to specific DNA regions to regulate gene expression. This epigenetic mechanism supports tissue repair and improves cardiovascular function, particularly benefiting the heart and blood vessels.
Cardiogen works through epigenetic regulation by penetrating cell nuclei and interacting with specific DNA regions, histones, and nucleosomes. It regulates which genes are activated or suppressed without changing DNA sequence. This mechanism supports cardiac tissue repair, enhances myocardial function, and improves cardiovascular tissue regeneration by influencing gene expression in heart cells.
Molecular Data
AEDRAlanine
Position 1
Glutamic Acid
Position 2
Aspartic Acid
Position 3
Arginine
Position 4
Accumulation Curve
Example inputs are illustrative, not a dosing protocol.
Research Indications
Supports heart tissue repair through gene expression regulation at the nuclear level.
May improve overall myocardial function and cardiac performance.
Addresses age-related cardiovascular decline through bioregulation.
Influences gene expression to support tissue repair without altering DNA sequence.
Promotes cardiac tissue regeneration at the cellular level.
Dosing Protocols
Available in capsule form for oral administration. Short peptides can be absorbed orally and reach target tissues. Typical protocol involves 10-20 day cycles, often repeated 2-3 times per year.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Standard protocol | 10-20 mg | Daily for 10-20 days | Oral capsules |
| Maintenance | 10 mg | 2-3 cycles yearly | Oral capsules |
Injectable form available for direct administration, bypassing GI tract.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Research protocol | 10 mg | Daily for 10 days | IM or SubQ |
Reconstitution Instructions
- Bacteriostatic water
- Insulin syringes
- Alcohol swabs
- Sterile vial
- 1 Clean work area thoroughly
- 2 Reconstitute with appropriate volume
- 3 Gently swirl until dissolved
- 4 Store reconstituted solution refrigerated
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
- Generally well-tolerated
- Minimal side effects reported
Stop Signs - Discontinue if:
- Allergic reactions
- Unusual cardiac symptoms
Contraindications
- Active cardiac emergencies (seek medical care)
- Known hypersensitivity
- Pregnancy or breastfeeding
Quality Checklist
Good Signs
- White powder or capsules
- Clear solution if reconstituted
- Proper packaging and labeling
Warning Signs
- Unknown source or purity
Bad Signs
- Discoloration
- Unusual odor
- Damaged packaging
Frequently Asked Questions
How does Cardiogen improve cardiac function if it's just 4 amino acids?
Cardiogen's short tetrapeptide (AEDR) penetrates directly into cell nuclei where it regulates cardiac gene expression epigenetically. Despite being only 4 amino acids, this structure is sufficient for DNA binding and histonemodulation, allowing it to influence which genes are activated in heart tissue without altering DNA sequence itself.
Can Cardiogen help after a heart attack or cardiac event?
Cardiogen's mechanism supports post-cardiac event recovery by promoting cardiac tissue repair and myocardial function improvement through gene expression modulation. However, no clinical human data exists on cardiac event recovery. This remains theoretical based on mechanisms and traditional use in Russian medicine.
Is Cardiogen safe for people with existing heart conditions?
Cardiogen is well-tolerated with minimal side effects reported. People with cardiac conditions should consult healthcare providers before use. Active cardiac emergencies require immediate medical care, not peptide therapy. For chronic cardiovascular support, medical supervision is prudent.
How often should I cycle Cardiogen for heart health maintenance?
Standard protocol is 10-20 day cycles repeated 2-3 times yearly for cumulative cardiovascular benefits. Effects persist between cycles due to epigenetic changes. Some users perform cycles seasonally, while others maintain 2-3 yearly cycles consistently for long-term cardiac tissue support and age-related decline prevention.
References
- Peptide Regulation of Gene Expression: A Systematic ReviewMolecules (MDPI) (2021)
Short peptides can penetrate nuclei, interact with DNA and histones to regulate gene expression.
- Cardiogen Bioregulator ResearchBulletin of Experimental Biology and Medicine (2015)
Demonstrated effects on cardiac tissue through gene expression modulation.
- Khavinson Peptide Bioregulators OverviewAdvances in Gerontology (2020)
Comprehensive review of bioregulator peptides and their epigenetic mechanisms.
Related Peptides
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.
For education and research information only. Not individualized medical advice.